Summary
Lymphocytes from patients with tumors of the bladder or other unrelated tissues or with non-malignant genitourinary (GU) conditions and from normal subjects were tested in a microcytotoxicity assay against long- and short-term cultures (T24 and BT) derived from bladder carcinoma and several other target cell types, to determine the validity of the hypothesis that cell-mediated cytotoxicity (CMC) in bladder cancer patients is a specific disease-related phenomenon. At the effector cell level, lymphocytes from bladder cancer patients displayed uniformly greater cytotoxicity for T24 and BT cells than those from normal donors. This proclivity was shared by the lymphocytes of patients with non-GU cancers but not of those with non-malignant GU disorders. At the target cell level, CMC was observed less frequently against non-bladder tumor targets than against T24 and BT cells and the CMC of bladder cancer patients did not differ significantly from that of the other groups. The pattern of CMC observed against the bladder tumor-derived targets was thus one of target cell sensitivity rather than tumor-specificity and disease-related only to the extent that the CMC of patients with cancer was greater overall than of healthy subjects. Abrogation of CMC by passage of lymphocytes through immunoglobulin-coated columns indicated that the effector cells were principally of non-T type, bearing a superficial resemblance to those in normal individuals which induce non-disease related CMC.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bean, M. A., Pees, H., Rosen, G., Oettgen, M. F.: Prelabeling target cells with 3H-proline as a method for studying lymphocyte cytotoxicity. Nat. Cancer Inst. Mongr. 37, 41–48 (1973)
Bean, M. A., Pees, H., Fogh, J. E., Grabstald, H., Oettgen, H. F.: Cytotoxicity of lymphocytes from patients with cancer of the urinary bladder. Detection by a 3H-proline microcytotoxicity test. Int. J. Cancer 14, 186–197 (1974)
Bean, M. A., Bloom, B. R., Herberman, R. B., Old, L. J., Oettgen, H. F., Klein, G., Terry, W. D.: Cell-mediated cytotoxicity for bladder carcinoma. Evaluation of a workshop. Cancer Res. 35, 2902–2913 (1975)
Bloom, E. T., Seeger, R. C.: Disease and non-disease-related cell-mediated cytotoxicity in humans. Cancer Res. 36, 1361–1366 (1976)
Bloom, E. T., Ossorio, R. C., Brosman, S. A.: Cell-mediated cytotoxicity against human bladder cancer. Int. J. Cancer 14, 326–334 (1974)
Boyle, W.: An extension of the 51Cr-release assay for the estimation of mouse cytotoxins. Transplantation 6, 761–764 (1968)
Bubenik, J., Perlmann, P., Helmstein, K., Moberger, G.: Immune response to urinary bladder tumours in man. Int. J. Cancer 5, 39–46 (1970a)
Bubenik, J., Perlmann, P., Helmstein, K., Moberger, G.: Cellular and humoral immune responses to human urinary bladder carcinomas. Int. J. Cancer 5, 310–319 (1970b)
Bubenik, J., Baresova, M., Viklicky, V., Jakoubkova, J., Sainerova, H., Donner, J.: Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen Int. J. Cancer 11, 765–773 (1973).
Coulson, A. S., Chalmers, D. G.: Separation of viable lymphocytes from human blood. Lancet I, 468–469 (1964)
DeVries, J. E., Meyering, M., Van Dongen, A., Rümke, P.: The influence of different isolation procedures and the use of target cells from melanoma cell lines and short-term cultures on the non-specific cytotoxic effects of lymphocytes from healthy donors. Int. J. Cancer, 15, 391–400 (1975)
Greenwalt, J. T., Gajewski, M., McKenna, J. C.: A new method for preparing buffy-coat-poor blood. Transfusion 2, 221–229 (1962)
Hakala, T. R., Lange, P. H., Fraley, E. E.: Human cell-mediated cytotoxicity estimated by lymphocyte titration. Cancer Res. 36, 2915–2922 (1976)
Hellström, I., Hellström, K. E., Sjogren, H. O., Warner, G. A.: Demonstration of cell-mediated immunity to human neoplasms of various histological types. Int. J. Cancer 7, 1–16 (1971)
Herberman, R. B., Oldham, R. K.: Problems associated with study of cell-mediated immunity to human tumours by microcytotoxicity assays. J. Nat. Cancer Inst. 55, 749–753 (1975)
Hersey, P., Edwards, A., Edwards, J., Adams, E., Milton, G. W., Nelson, D. S.: Specificity of cell-mediated cytotoxicity against human melanoma lines: Evidence for “non-specific” killing by activated T cells. Int. J. Cancer 16, 173–183 (1975)
Kiuchi, M., Takasugi, M.: The nonselective cytotoxic cell (N cell). J. Nat. Cancer Inst. 56, 575–582 (1976)
Oldham, R. K., Siwarski, D., McCoy, J. L., Plata, E. J., Herberman, R. B.: Evaluation of cell-mediated cytotoxicity assay utilizing 125iododeoxyuridine-labelled tissue culture target cells. Nat. Cancer Inst. Monogr. 37, 49–58 (1973)
Oldham, R. K., Djeu, J. Y., Cannon, G. B. Siwarski, D., Herberman, R. B.: Cellular microcytotoxicity in human tumour systems; analysis of results. J. Nat. Cancer Inst. 55, 1305–1318 (1975)
O'Toole, C., Perlmann, P., Unsgaard, B., Moberger, G., Edsmyr, F.: Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy. Int. J. Cancer 10, 77–91 (1972)
O'Toole, C., Unsgaard, B., Almgard, L. E., Johansson, B.: The cellular immune response to carcinoma of the urinary bladder: correlation to clinical stage and treatment. Brit. J. Cancer, 28, (Suppl. 1), 266–275 (1973a)
O'Toole, C., Perlmann, P., Wigzell, H., Unsgaard, B., Zetterlund, C. G.: Lymphocyte cytotoxicity in bladder cancer. No requirement for thymus derived effector cells. Lancet I, 1085–1088 (1973b)
O'Toole, C., Stejskal, V., Perlmann, P., Karlsson, M.: Lymphoid cells mediating tumour-specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector population using a surface marker. J. exp. Med. 139, 457–466 (1974)
Pavie-Fischer, J., Kourilsky, F. M., Picard, F., Banzet, P., Puissant, A.: Cytotoxicity of lymphocytes from healthy subjects and from melanoma patients against cultured melanoma cells. Clin. exp. Immunol. 21, 430–441 (1975)
Peter, H. H., Pavie-Fischer, J., Fridman, W. H., Aubert, C., Cesarini, J.-P., Roubin, R., Kourilsky, F. M.: Cell-mediated cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (IGR3). J. Immunol. 115, 539–548 (1975)
Pierce, G. E., Devald, B. L.: Effects of human lymphocytes on cultured normal and malignant cells. Cancer Res. 35, 1830–1839 (1975)
Potter, M. R., Moore, M.: PHA stimulation of separated human lymphocyte populations. Clin. exp. Immunol. 21, 456–467 (1975)
Siegel, S.: Non parametric statistics for the behavioral sciences, pp. 75–83 and 116–127. New York-Toronto-London: McGraw Hill 1956
Skurzak, H., Steiner, L., Klein, E., Lamon, E.: Cytotoxicity of human peripheral lymphocytes for glioma, osteosarcoma and glia cell lines. Nat. Cancer Inst. Monogr. 37, 93–102 (1973)
Takasugi, M., Klein, E.: A microassay for cell-mediated immunity. Transplantation 9, 219–227 (1970)
Takasugi, M., Mickey, M. R., Terasaki, P. I.: Reactivity of lymphocytes from normal persons on cultured tumour cells. Cancer Res. 33, 2898–3902 (1973)
Takasugi, M., Akira, D., Kinoshita, K.: Granulocytes as effectors in cell-mediated cytotoxicity of adherent target cells. Cancer Res. 35, 2169–2176 (1975)
UICC (Union Internationale Contre le Cancer): Cancer of the urinary bladder. Basle-New York: Karger 1963
Vose, B. M., Moore, M., Jack, G. D.: Cell-mediated cytotoxicity to human pulmonary neoplasms. Int. J. Cancer 15, 308–320 (1975a)
Vose, B. M., Moore, M., Schofield, P. F., Dymock, I. W.: Leucocytotoxicity in malignant and non-malignant colonic diseases. Clin. exp. Immunol. 22, 393–398 (1975b)
Vose, B. M., Moore, M.: Reactivity of peripheral blood leucocytes against human foetal cells. Europ. J. Cancer 12, 639–649 (1976a)
Vose, B. M., Moore, M.: Reactivity of peripheral blood leucocytes against human foetal cells. II. Cytotoxic potential of preparations enriched or depleted of different leucocyte populations. Int. J. Cancer 19, (1977) (In press)
Wigzell, H., Sundquist, K. G., Yoshida, T. O.: Separation of cells according to surface antigens by the use of antibody-coated columns. Fractionation of cells carrying immunoglobulins and blood group antigens. Scand. J. Immunol. 1, 75–87 (1972)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moore, M., Robinson, N. Cell-mediated cytotoxicity in carcinoma of the human urinary bladder. Cancer Immunol Immunother 2, 233–243 (1977). https://doi.org/10.1007/BF00206005
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00206005